Can’t see the audio participant? Click on right here to pay attention on Acast. You too can pay attention on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you hearken to podcasts.
With covid caseloads rising throughout a lot of the nation, a number of governors and mayors are unilaterally increasing entry to booster pictures, getting out forward of federal well being officers.
Talking of federal well being officers, President Joe Biden has lastly chosen a nominee to move the Meals and Drug Administration. If confirmed by the Senate, it will be Dr. Robert Califf’s second stint on the company that oversees an estimated one fifth of all merchandise bought in the US. Califf beforehand served — for lower than a 12 months — below President Barack Obama.
Califf’s nomination, nonetheless, could possibly be difficult by the information of a dramatic enhance in Medicare premiums for 2022, prompted largely by the FDA’s approval of a controversial drug to deal with Alzheimer’s illness not but been proved efficient.
This week’s panelists are Julie Rovner of KHN, Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat.
Among the many takeaways from this week’s episode:
- Democratic leaders within the Home say they count on to vote quickly on a invoice funding Biden’s local weather change and social coverage agenda. Even some moderates, who’ve been involved concerning the price ticket, counsel that passage appears to be like probably. However the Congressional Price range Workplace has not but launched its full estimates of the price of among the extra controversial well being objects within the invoice, and people numbers might immediate requires revisions.
- Califf seems on observe for Senate affirmation as a result of he’s anticipated to get assist from most Democrats and a few Republicans. A number of Democrats, nonetheless, have already criticized the nomination, complaining the FDA was not robust sufficient on the drugmakers behind the opioid epidemic and desires a pacesetter who will change that tradition.
- On the Division of Well being and Human Companies, not less than three Senate-confirmed positions coping with social companies stay unfilled. These embody the assistant secretary for the Administration for Youngsters and Households, a commissioner for the Administration for Native People and a commissioner for that company’s kids, youth and households bureau.
- Medicare officers introduced the usual month-to-month premium for the Half B program, which covers physician and different outpatient medical companies, would rise subsequent 12 months by greater than $20. A part of that enhance is a hedge in case Medicare decides to cowl the price of a brand new controversial Alzheimer’s drug, Aduhelm.
- Aduhelm is priced at $56,000 a 12 months and includes different prices associated to testing for uncomfortable side effects. Though the drug would probably be utilized by a small variety of beneficiaries, its excessive value influenced the sharp enhance in premiums, Medicare officers mentioned.
- If Medicare opts to not cowl Aduhelm, it’s not clear if or how beneficiaries would possibly recoup the cash spent on the premiums.
- The FDA seems to be transferring towards the Biden administration’s want to make all American adults eligible for added covid vaccine pictures, referred to as boosters. Some scientists throughout the administration have been reluctant to take that step, however new proof offered by the drugmakers bolsters the trouble to get youthful individuals additional doses.
- The transfer by states and cities to make youthful adults eligible for the boosters might not be authorized below the special-use authorization the FDA gave a number of of the vaccines. Nevertheless it hasn’t been challenged.
- Confusion over who’s eligible for the pictures could undermine the federal authorities’s efforts to guarantee the nation that the covid vaccines are efficient and a good selection. Nonetheless, individuals hesitant to get the pictures don’t seem like satisfied by many arguments.
- Biden’s order that giant workplaces set up vaccine mandates is on maintain as it’s being challenged in federal court docket. The problem will probably find yourself earlier than the Supreme Courtroom, and a few advocates for employees concern that the justices might use the case as a chance to roll again federal protections within the office.
Additionally this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast, about his new challenge, a “first-aid equipment” publication to assist shoppers make higher selections about their very own well being care.
Plus, for additional credit score, the panelists suggest their favourite well being coverage tales of the week they assume it’s best to learn, too:
Julie Rovner: The Atlantic’s “Why Well being-Care Staff Are Quitting in Droves,” by Ed Yong.
Additionally, Stat’s “The Catholic Hospital System Ascension Is Working a Wall Avenue-Type Non-public Fairness Fund,” by Rachel Cohrs.
Tami Luhby: Politico’s “‘We Don’t Repair This As a result of We Simply Don’t Care About Previous Individuals,’” by Joanne Kenen.
Sarah Karlin-Smith: KHN and InvestigateTV’s “As Massive Pharma and Hospitals Battle Over Drug Reductions, Sufferers Miss Out on Hundreds of thousands in Advantages,” by Sarah Jane Tribble and Emily Featherston.
Rachel Cohrs: Trendy Healthcare’s “Why the Justice Division Is Concentrating on Non-public Fairness,” by Tara Bannow.
To listen to all our podcasts, click on right here.
And subscribe to KHN’s What the Well being? on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you hearken to podcasts.
Submit a Story Tip